Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2155320rdf:typepubmed:Citationlld:pubmed
pubmed-article:2155320lifeskim:mentionsumls-concept:C0031381lld:lifeskim
pubmed-article:2155320lifeskim:mentionsumls-concept:C0079883lld:lifeskim
pubmed-article:2155320lifeskim:mentionsumls-concept:C0005456lld:lifeskim
pubmed-article:2155320lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:2155320lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:2155320lifeskim:mentionsumls-concept:C0038477lld:lifeskim
pubmed-article:2155320lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:2155320lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:2155320pubmed:issue3lld:pubmed
pubmed-article:2155320pubmed:dateCreated1990-4-6lld:pubmed
pubmed-article:2155320pubmed:abstractTextA series of eight C5-substituted analogues of (+-)-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (1) have been prepared by the directed lithiation-alkylation (and acylation) of its (+-)-N-tert-butylformamidinyl derivative 2 followed by formamidine solvolysis. An additional 10 analogues were prepared by elaboration of the C5-ethyl ester derivative. Analogues possessing large (e.g. propyl and larger) lipophilic substituents displace [3H]-1-(1-thienylcyclohexyl)piperidine [( 3H]TCP) from the high-affinity phencyclidine (PCP) binding site in rat brain homogenates only at high concentrations (Ki greater than 1000 nM); however, the presence of a polar amino functionality (e.g. 2-aminoethyl) offsets this effect (Ki = 20 nM). Thus, the boundary condition for lipophilic substituents larger than ethyl appears to be polar in nature. Interaction of the 11 relatively small (MR less than 14) C5-substituted analogues of 1 with the high-affinity PCP binding site associated with the N-methyl-D-aspartate (NMDA) receptor is best described by the equation log (1/Ki) = -5.83F + 0.64 pi + 7.41 (r = 0.90).lld:pubmed
pubmed-article:2155320pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2155320pubmed:languageenglld:pubmed
pubmed-article:2155320pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2155320pubmed:citationSubsetIMlld:pubmed
pubmed-article:2155320pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2155320pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2155320pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2155320pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2155320pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2155320pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2155320pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2155320pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2155320pubmed:statusMEDLINElld:pubmed
pubmed-article:2155320pubmed:monthMarlld:pubmed
pubmed-article:2155320pubmed:issn0022-2623lld:pubmed
pubmed-article:2155320pubmed:authorpubmed-author:JacobsonA EAElld:pubmed
pubmed-article:2155320pubmed:authorpubmed-author:RiceK CKClld:pubmed
pubmed-article:2155320pubmed:authorpubmed-author:MonnJ AJAlld:pubmed
pubmed-article:2155320pubmed:authorpubmed-author:MattsonM VMVlld:pubmed
pubmed-article:2155320pubmed:authorpubmed-author:ThurkaufAAlld:pubmed
pubmed-article:2155320pubmed:issnTypePrintlld:pubmed
pubmed-article:2155320pubmed:volume33lld:pubmed
pubmed-article:2155320pubmed:ownerNLMlld:pubmed
pubmed-article:2155320pubmed:authorsCompleteYlld:pubmed
pubmed-article:2155320pubmed:pagination1069-76lld:pubmed
pubmed-article:2155320pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2155320pubmed:meshHeadingpubmed-meshheading:2155320-...lld:pubmed
pubmed-article:2155320pubmed:meshHeadingpubmed-meshheading:2155320-...lld:pubmed
pubmed-article:2155320pubmed:meshHeadingpubmed-meshheading:2155320-...lld:pubmed
pubmed-article:2155320pubmed:meshHeadingpubmed-meshheading:2155320-...lld:pubmed
pubmed-article:2155320pubmed:meshHeadingpubmed-meshheading:2155320-...lld:pubmed
pubmed-article:2155320pubmed:meshHeadingpubmed-meshheading:2155320-...lld:pubmed
pubmed-article:2155320pubmed:meshHeadingpubmed-meshheading:2155320-...lld:pubmed
pubmed-article:2155320pubmed:meshHeadingpubmed-meshheading:2155320-...lld:pubmed
pubmed-article:2155320pubmed:meshHeadingpubmed-meshheading:2155320-...lld:pubmed
pubmed-article:2155320pubmed:meshHeadingpubmed-meshheading:2155320-...lld:pubmed
pubmed-article:2155320pubmed:meshHeadingpubmed-meshheading:2155320-...lld:pubmed
pubmed-article:2155320pubmed:meshHeadingpubmed-meshheading:2155320-...lld:pubmed
pubmed-article:2155320pubmed:year1990lld:pubmed
pubmed-article:2155320pubmed:articleTitleSynthesis and structure-activity relationship of C5-substituted analogues of (+-)-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine [(+-)-desmethyl-MK801]: ligands for the NMDA receptor-coupled phencyclidine binding site.lld:pubmed
pubmed-article:2155320pubmed:affiliationLaboratory of Medicinal Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.lld:pubmed
pubmed-article:2155320pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2155320pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:2155320pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2155320pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:2155320lld:chembl